Basmah Almohaywi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Advanced Non Small Cell Lung Cancer

Molecular Docking

Epidermal Growth Factor Receptor

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed K B Aljohani, Khaled El-Adl, Basmah Almohaywi, Omar M Alatawi, Marwa Alsulaimany, Ahmed El-Morsy, Sara A Almadani, Hussam Y Alharbi, Majed S Aljohani, Felemban Athary Abdulhaleem M, Hanan E M Osman, Samy Mohamady
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFR WT and EGFR T790M : design, synthesis, ADMET and molecular docking. RSC advances 14 (12) (2024)
Ahmed K B Aljohani, Khaled El-Adl, Basmah Almohaywi, Omar M Alatawi, Marwa Alsulaimany, Ahmed El-Morsy, Sara A Almadani, Hussam Y Alharbi, Majed S Aljohani, Felemban Athary Abdulhaleem M, Hanan E M Osman, Samy Mohamady
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFR WT and EGFR T790M : design, synthesis, ADMET and molecular docking. RSC advances 14 (12) (2024)
Basmah Almohaywi, Tsz Tin Yu, George Iskander, Shekh Sabir, Mohan Bhadbhade, David StClair Black, Naresh Kumar
Synthesis of Alkyne-Substituted Dihydropyrrolones as Bacterial Quorum-Sensing Inhibitors of Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 11 (2) (2022)